IL148241A0 - A composition for inhalation containing delta-9-tetrahydrocannabinol - Google Patents
A composition for inhalation containing delta-9-tetrahydrocannabinolInfo
- Publication number
- IL148241A0 IL148241A0 IL14824100A IL14824100A IL148241A0 IL 148241 A0 IL148241 A0 IL 148241A0 IL 14824100 A IL14824100 A IL 14824100A IL 14824100 A IL14824100 A IL 14824100A IL 148241 A0 IL148241 A0 IL 148241A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydrocannabinol
- delta
- formulation
- composition
- inhalation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15002399P | 1999-08-20 | 1999-08-20 | |
PCT/US2000/022495 WO2001013886A1 (en) | 1999-08-20 | 2000-08-15 | Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148241A0 true IL148241A0 (en) | 2002-09-12 |
Family
ID=22532791
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14824100A IL148241A0 (en) | 1999-08-20 | 2000-08-15 | A composition for inhalation containing delta-9-tetrahydrocannabinol |
IL148241A IL148241A (en) | 1999-08-20 | 2002-02-19 | Composition for inhalation containing delta-9-tetrahydrocannabinol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL148241A IL148241A (en) | 1999-08-20 | 2002-02-19 | Composition for inhalation containing delta-9-tetrahydrocannabinol |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1212039B1 (da) |
JP (1) | JP2003535813A (da) |
CN (1) | CN1187093C (da) |
AT (1) | ATE308314T1 (da) |
AU (1) | AU779324B2 (da) |
CA (1) | CA2382217A1 (da) |
DE (1) | DE60023720T2 (da) |
DK (1) | DK1212039T3 (da) |
ES (1) | ES2246883T3 (da) |
HK (1) | HK1056318A1 (da) |
IL (2) | IL148241A0 (da) |
MX (1) | MXPA02001804A (da) |
NO (1) | NO20020835L (da) |
NZ (1) | NZ517517A (da) |
WO (1) | WO2001013886A1 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6747058B1 (en) | 1999-08-20 | 2004-06-08 | Unimed Pharmaceuticals, Inc. | Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
US7648696B2 (en) | 1999-08-20 | 2010-01-19 | Unimed Pharmaceuticals, Llc | Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
ATE353629T1 (de) * | 2000-03-09 | 2007-03-15 | Gw Pharma Ltd | Cannabis enthaltende pharmazeutische zusammensetzungen |
GB2361869B (en) * | 2000-03-09 | 2004-09-22 | Pharmasol Ltd | Sublingual delivery of cannabis |
GB2392093B (en) * | 2002-08-14 | 2006-03-08 | Gw Pharma Ltd | Pharmaceutical formulations |
ES2625605T3 (es) * | 2002-08-14 | 2017-07-20 | Gw Pharma Limited | Formulaciones líquidas cannabinoides para administración a la mucosa bucal |
WO2007041167A2 (en) | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
GB2431105A (en) | 2005-10-12 | 2007-04-18 | Gw Pharma Ltd | Cannabinoids for the treatment of pulmonary disorders |
GB2524469A (en) * | 2014-02-14 | 2015-09-30 | Kind Consumer Ltd | A cannabinoid inhaler and composition therefor |
US9918961B2 (en) | 2014-02-19 | 2018-03-20 | Kind Consumer Limited | Cannabinoid inhaler and composition therefor |
US11331279B2 (en) | 2014-05-29 | 2022-05-17 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
EP4151234A1 (en) * | 2014-05-29 | 2023-03-22 | Fresh Cut Development, LLC | Stable cannabinoid formulations |
US11911361B2 (en) | 2014-05-29 | 2024-02-27 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
CA3111682A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
CN110200953B (zh) * | 2019-06-15 | 2022-02-08 | 汉义生物科技(北京)有限公司 | 大麻素在制备吸入给药药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509005B1 (en) * | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
-
2000
- 2000-08-15 AU AU69107/00A patent/AU779324B2/en not_active Ceased
- 2000-08-15 CA CA002382217A patent/CA2382217A1/en not_active Abandoned
- 2000-08-15 CN CNB008131953A patent/CN1187093C/zh not_active Expired - Fee Related
- 2000-08-15 MX MXPA02001804A patent/MXPA02001804A/es active IP Right Grant
- 2000-08-15 ES ES00957496T patent/ES2246883T3/es not_active Expired - Lifetime
- 2000-08-15 DE DE60023720T patent/DE60023720T2/de not_active Expired - Lifetime
- 2000-08-15 EP EP00957496A patent/EP1212039B1/en not_active Expired - Lifetime
- 2000-08-15 DK DK00957496T patent/DK1212039T3/da active
- 2000-08-15 JP JP2001518025A patent/JP2003535813A/ja active Pending
- 2000-08-15 AT AT00957496T patent/ATE308314T1/de not_active IP Right Cessation
- 2000-08-15 WO PCT/US2000/022495 patent/WO2001013886A1/en active IP Right Grant
- 2000-08-15 IL IL14824100A patent/IL148241A0/xx active IP Right Grant
- 2000-08-15 NZ NZ517517A patent/NZ517517A/en unknown
-
2002
- 2002-02-19 IL IL148241A patent/IL148241A/en unknown
- 2002-02-20 NO NO20020835A patent/NO20020835L/no not_active Application Discontinuation
-
2003
- 2003-11-26 HK HK03108637A patent/HK1056318A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2246883T3 (es) | 2006-03-01 |
EP1212039A1 (en) | 2002-06-12 |
AU779324B2 (en) | 2005-01-20 |
HK1056318A1 (en) | 2004-02-13 |
DE60023720T2 (de) | 2006-07-20 |
WO2001013886A1 (en) | 2001-03-01 |
ATE308314T1 (de) | 2005-11-15 |
AU6910700A (en) | 2001-03-19 |
CN1420761A (zh) | 2003-05-28 |
IL148241A (en) | 2007-02-11 |
DK1212039T3 (da) | 2005-12-19 |
NO20020835L (no) | 2002-04-02 |
EP1212039B1 (en) | 2005-11-02 |
MXPA02001804A (es) | 2004-09-06 |
CN1187093C (zh) | 2005-02-02 |
CA2382217A1 (en) | 2001-03-01 |
NZ517517A (en) | 2004-03-26 |
JP2003535813A (ja) | 2003-12-02 |
NO20020835D0 (no) | 2002-02-20 |
DE60023720D1 (de) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148241A0 (en) | A composition for inhalation containing delta-9-tetrahydrocannabinol | |
US4912124A (en) | Antifungal dermatological solution | |
EP1073439A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
FI952842A0 (fi) | Stabiloitu lääkeaerosolin liuosvalmiste | |
WO2003035051A3 (en) | The use of proton sequestering agents in drug formulations | |
AU2001288460A1 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
CA2215327A1 (en) | Formulations for lipophilic compounds | |
AU669122B2 (en) | New pyrazine derivatives, their preparation and their use | |
AU4419497A (en) | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form | |
CA2376303A1 (en) | Stabilized vitamin c formulations | |
JPS6431727A (en) | Dissolution of argininamide and drug composition containing argininamides | |
ES2174388T3 (es) | Solucion liquida de medicamento para administracion oral. | |
ATE14437T1 (de) | Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel. | |
DE69829849D1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
ATE228842T1 (de) | Codein enthaltende formulierungen | |
JPS59101478A (ja) | リグスチライドを安定に配合した水系組成物 | |
US4089968A (en) | Stable solutions of ipronidazole | |
CO4370014A1 (es) | Soluciones inyectables estables de diritromicina | |
JPH034079B2 (da) | ||
AU6015398A (en) | Method for removing high boiling solvents from drug formulations by vacuum drying | |
JPS5798208A (en) | Ointment base | |
HUT62314A (en) | Process for producing new opioid receptorantagonist penta- and hexapeptide derivatives and pharmaceutical compositions comprising same as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB20 | Patent renewed for 20 years |